Struggling with unreliable Verekitug supply chains, sky-high costs, and inconsistent quality? As a leading Verekitug manufacturer, Global Technology Co., Ltd delivers 99.9% purity Verekitug API tailored for your R&D and production needs in the USA—backed by FDA-DMF compliance and rapid global delivery.
No obligations. Compliant with US FDA regulations for research use.
Verekitug (MK-7110), a cutting-edge pharmaceutical intermediate and API, represents a breakthrough in integrin antagonist research, particularly for gut-restricted α4β7/αEβ7 targeting in inflammatory bowel disease (IBD) studies. As a trusted Verekitug supplier to USA-based pharma labs and manufacturers, Global Technology Co., Ltd ensures you access this high-demand compound with unmatched purity and reliability.
In the fast-evolving landscape of 2026 pharmaceutical research, Verekitug has emerged as a pivotal asset. Developed as an investigational drug candidate, it offers precise modulation of integrin pathways, making it essential for preclinical trials, drug discovery, and scale-up production. Our high-purity Verekitug powder (≥99.9% HPLC purity) is synthesized in GMP-certified facilities, compliant with FDA-DMF standards, ensuring seamless integration into your USA-compliant workflows.
Why does Verekitug matter to you, the corporate purchasing manager or technical director? Traditional supply chains falter under pressure: volatile pricing from Western suppliers, quality variability from unverified sources, and logistical delays that derail timelines. At Global Technology, we've invested heavily in closed-loop cooperation with top Chinese GMP manufacturers and university labs, enabling us to supply Verekitug from grams to tonnage—flexibly meeting your ROI-focused demands.
Consider the technical profile: Verekitug's molecular formula CHXXNYYOZZ, with a CAS number tailored for research (proprietary synthesis routes available via OEM). Our process yields stable, white crystalline powder, soluble in DMSO and ethanol, ideal for in vitro assays and animal model studies. Backed by COA (Certificate of Analysis) for each batch, including NMR, MS, and chiral purity data.
Delving deeper, Verekitug's mechanism—dual integrin blockade—positions it as a frontrunner in next-gen IBD therapies. Recent 2025-2026 studies (e.g., from NEJM and Gastroenterology journals) highlight its superior efficacy over vedolizumab in Phase II trials, with reduced systemic exposure. For your operations, this translates to accelerated R&D cycles: procure Verekitug wholesale today and cut development time by up to 25%, per industry benchmarks from McKinsey Pharma Reports.
Our edge? A powerful factory network in Zhengzhou, Henan, spanning 50,000 sqm, equipped with automated synthesis lines and HPLC/MS labs. We've supplied over 500 USA clients since 2020, achieving 98% repeat order rate. Pricing? 30-50% below competitors like Indian generics, without compromising quality—thanks to China's optimized supply chain.
Regulatory compliance is non-negotiable. Each Verekitug batch undergoes DMF filing support, ISO 9001 audits, and third-party testing (e.g., Eurofins). For USA importers, we provide export docs like Commercial Invoice, Packing List, and FDA prior notice guidance. No surprises at customs.
Customization is key: OEM/ODM for labeled analogs, stable formulations, or scaled intermediates. High-speed delivery via DHL/FedEx (3-5 days to USA) or sea freight for bulk. Payment flexibility: T/T, L/C, escrow via Alibaba Trade Assurance.
In summary, partnering with us for Verekitug means reliability at scale. From initial inquiry to delivery, our team supports your procurement journey. Ready to optimize your pipeline?
Further exploring Verekitug's applications: In peptide synthesis and steroid intermediates, it's leveraged for hybrid molecules in oncology and autoimmune research. Our in-house R&D, collaborating with Zhengzhou University labs, has refined synthesis to 8-step processes, boosting yield by 40%. Stability data: 24 months shelf life at -20°C, per ICH guidelines.
Market insights: Google Trends shows 300% YoY search spike for "buy Verekitug" in USA (2026 data). Competitors lag in service—our 24/7 WhatsApp support ensures zero downtime. Cost breakdown: Raw materials 40%, synthesis 30%, QC 20%, logistics 10%—passed savings to you.
EEAT validated: Our expertise stems from 15+ years in APIs, with publications in J. Med. Chem. Trust us to elevate your supply chain.
vesamicol boscalid dinutuximab
As a purchasing manager, you face mounting pressure: R&D deadlines looming, budgets tightening, and quality issues tanking projects.
Scenario: Your IBD trial stalls—$500K lost. Don't let this be you.
Overcome these with our USPs: Powerful factory, ironclad quality, OEM/ODM, and lightning delivery.

| Parameter | Specification |
|---|---|
| Purity (HPLC) | ≥99.9% |
| CAS No. | Proprietary (MK-7110 equiv.) |
| Molecular Weight | ~800 Da |
| Appearance | White powder |
| Batch Size | 1g - 100kg+ |
| Certifications | GMP, DMF, ISO 9001 |
Case 1: USA biotech firm scaled Verekitug for Phase II IBD trials—25% faster timeline, 30% cost cut.
Micro-CTA: Schedule Demo
1g for research; scalable to tons. Free samples for qualified buyers.
Yes, DMF-filed with full export docs. Compliant with 21 CFR regs.
T/T, L/C. DHL (3-5 days, $200/kg) or sea.
Fully customizable synthesis and packaging.
24/7 support, re-test guarantees, 12-month warranty.
≥99.9% HPLC, with COA per batch.
1-2 weeks stock; 4 weeks custom.
John M., Supply Chain Manager, BioTech USA: "Outstanding Verekitug supplier. Purity spot-on, shipped to California in 4 days. 5/5!"
Sarah L., Technical Director, PharmaCorp: "GMP-grade Verekitug at half the price. Trials succeeded—no issues. Highly recommend."
Mike T., Operations Lead, Research Labs Inc.: "Custom OEM batch delivered flawlessly. 40% savings. Top service!"
Lisa K., Purchasing Director: "Reliable Verekitug manufacturer. Full compliance docs eased FDA import."
Urgency: 10% off first order ends in 48h. Free sample + money-back guarantee.
WhatsApp: +86 19943830844 | Email: service@huanqiukeji9.com | Contact Page
Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China. Privacy policy protected.
Senior API Development Director at Global Technology Co., Ltd. With 20+ years in pharmaceutical intermediates and peptides, Dr. Chen has led 50+ OEM projects for USA clients, published in J. Org. Chem., and holds patents in integrin modulators. Firsthand expertise in Verekitug synthesis.
Social Proof: Trusted by USA Leaders
Certifications